Opendata, web and dolomites

FRINGE SIGNED

Fluorescence and Reactive oxygen Intermediates by Neutron Generated electronic Excitation as a foundation for radically new cancer therapies

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 FRINGE project word cloud

Explore the words cloud of the FRINGE project. It provides you a very rough idea of what is the project "FRINGE" about.

disciplines    occult    interaction    gadolinium    compromised    designed    gd    ps    lying    chemists    therapies    contain    lack    photobiologists    ambient    physicists    therapeutic    centres    cancers    cell    accumulate    photomedical    marginal    reactive    pss    blood    synthetic    medical    limited    neutron    penetration    mainly    barrier    transfer    modality    scientific    tissue    combine    suffer    oncologists    join    aggressive    species    advantages    fluorescence    exactly    act    activated    radiation    agents    magnetic    genuinely    nuclear    experimental    oxygen    tumours    curative    resonance    forces    fringe    chemical    causing    confirmed    photochemists    metal    contrast    world    tuned    eliminate    quantum    proof    vaccine    energy    concomitant    generate    renowned    theranostic    combination    neutrons    radio    interdisciplinary    mutagenic    survival    light    cells    experts    externally    brain    hybrid    breakthrough    specificity    beam    preferentially    agent    therapy    death    insufficient    tumour    foundations    sufficient    excitation    cancer    photosensitisers    electron    emission    incoming    rates    lay    deep    immunogenic    imaging    metastasis    heart    treat    kill    team    difficult   

Project "FRINGE" data sheet

The following table provides information about the project.

Coordinator
OSLO UNIVERSITETSSYKEHUS HF 

Organization address
address: KIRKEVEIEN 166 TARNBYGGET
city: OSLO
postcode: 450
website: http://www.oslo-universitetssykehus.no

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Norway [NO]
 Total cost 3˙979˙485 €
 EC max contribution 3˙979˙485 € (100%)
 Programme 1. H2020-EU.1.2.1. (FET Open)
 Code Call H2020-FETOPEN-2018-2019-2020-01
 Funding Scheme RIA
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2023-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    OSLO UNIVERSITETSSYKEHUS HF NO (OSLO) coordinator 898˙118.00
2    "NATIONAL CENTER FOR SCIENTIFIC RESEARCH ""DEMOKRITOS""" EL (AGIA PARASKEVI) participant 719˙687.00
3    INSTITUTT FOR ENERGITEKNIKK NO (KJELLER) participant 559˙875.00
4    SYNTHETICA AS NO (OSLO) participant 446˙875.00
5    UNIVERSITAT POLITECNICA DE VALENCIA ES (VALENCIA) participant 384˙375.00
6    VYSOKA SKOLA CHEMICKO-TECHNOLOGICKA V PRAZE CZ (PRAHA) participant 382˙500.00
7    UNIVERSITAT DE GIRONA ES (GIRONA) participant 336˙250.00
8    ACCELOPMENT AG CH (ZUERICH) participant 251˙803.00

Map

 Project objective

Deep lying tumours like aggressive brain cancer remain very difficult to treat and existing therapies offer only marginal increase in survival rates. In the case of photomedical therapies they are very effective, but mainly limited by their insufficient depth of light penetration into tissue. Current neutron-based therapies have sufficient penetration depth but suffer from lack of cancer specificity. In FRINGE we propose a genuinely new hybrid-technology. At its heart are chemical agents (photosensitisers - PS) which preferentially accumulate in the tumours especially in brain cancers where the blood brain barrier is compromised. The PSs designed for FRINGE will contain metal centres like Gadolinium (Gd), to enable interaction with incoming neutrons and facilitate the transfer of neutron energy into electron excitation of the PS, confirmed by concomitant fluorescence emission. Interaction with ambient oxygen will generate reactive oxygen species which will kill the tumour cells. The main scientific breakthrough of this project will be to establish experimental proof-of-principle of this novel neutron-activated therapy. FRINGE will combine the advantages of photomedical therapies (no mutagenic radiation) with the advantages of neutron-based therapies (large penetration depth). The externally-applied neutron beam can be energy-tuned to become therapeutic exactly at the depth of the tumour. Exploiting Gd as a contrast agent, FRINGE can also become a theranostic modality by use of magnetic resonance imaging. FRINGE has the potential of causing immunogenic cell death to cancers which could eliminate occult metastasis and act as a ‘cancer vaccine’. The highly interdisciplinary project team comprises world renowned experts from a unique combination of disciplines: Nuclear physicists, synthetic chemists, photochemists, photobiologists, medical physicists, quantum chemists and radio-oncologists will join forces to lay the foundations for a novel, curative cancer therapy.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FRINGE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FRINGE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

PANACHE (2020)

Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases.

Read More  

LABELFREE (2019)

LABEL FREE IMAGING WITH PHI-SCAT

Read More  

EggSorter (2019)

Device and method for automatized egg cell inspection and sorting

Read More